Ambulatory medicament pump with safe access control

A computer-implemented method of enabling therapy change controls associated with a selected safe access level for a user of an ambulatory medicament pump configured to provide medicament therapy to a subject, wherein the medicament therapy comprises infusing a medicament to the subject, the computer-implemented method comprising:

• by a hardware processor of an ambulatory medicament pump, wherein the hardware processor is configured to execute specific computer-executable instructions stored in a non-transitory memory in communication with the hardware processor:
• receiving, via a digital data interface, an access signal from an electronic access device, wherein the access signal is configured to enable one or more therapy change controls associated with a selected safe access level, wherein the selected safe access level is associated with at least one of a plurality of safe access level profiles, each safe access level profile specifying therapy change controls associated with a safe access level, and wherein the one or more therapy change controls affect administration of medicament therapy by the ambulatory medicament pump;
• and
• in response to receiving the access signal, enabling the one or more therapy change controls associated with the safe access level, wherein selecting a medicament therapy setting using the one or more therapy change controls causes modification of a control parameter used by a control algorithm to affect administration of the medicament therapy by the ambulatory medicament pump.

A computer-implemented method of managing access to therapy change controls of an ambulatory medicament pump configured to provide medicament therapy to a subject, the computer-implemented method comprising:

• by a hardware processor of an electronic evaluation device, wherein the hardware processor is configured to execute specific computer-executable instructions stored in the electronic evaluation device to determine a safe access level from a plurality of safe access levels:
• receiving, from an electronic device in communication with the electronic evaluation device, evaluation data associated with a subject, wherein the evaluation data comprises therapy data corresponding to glycemic control of the subject by an ambulatory medicament pump;
• determining the safe access level for a user of the ambulatory medicament pump based at least in part on the evaluation data, wherein the safe access level is associated with a plurality of therapy change controls of the ambulatory medicament pump, and wherein the plurality of therapy change controls comprise a control for selecting a medicament therapy setting that affects administration of medicament therapy by the ambulatory medicament pump;
• determining, based at least in part on the evaluation data, a validity period during which the plurality of therapy change controls are enabled;
• generating an access signal that, when received by the ambulatory medicament pump, is configured to cause the plurality of therapy change controls to be enabled during the validity period;
• and
• transmitting the access signal to the ambulatory medicament pump via a data connection.